Approval · Notice of Compliance 25992 · 2021
ZYBAN: Notice of Compliance 25992
Issued June 4, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25992
- Date
- June 4, 2021
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Updates to the product monograph. change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZYBAN | 02238441 | Marketed |
Medicinal ingredients
- BUPROPION HYDROCHLORIDE 150 MG per TAB